LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF
The present invention relates to a liquid botulinum toxin formulation comprising: (i) botulinum toxin, (ii) a stabilizing protein such as human serum albumin, (iii) a chelating agent (e.g., EDTA) or phosphate, and optionally (iv) a salt of calcium, magnesium or zinc, (v) a tonicity agent and/or (vi)...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TAYLOR, Harold V KÜHBACH, Katja JATZKE, Claudia FINK, Klaus EISELE, Karl-Heinz |
| description | The present invention relates to a liquid botulinum toxin formulation comprising: (i) botulinum toxin, (ii) a stabilizing protein such as human serum albumin, (iii) a chelating agent (e.g., EDTA) or phosphate, and optionally (iv) a salt of calcium, magnesium or zinc, (v) a tonicity agent and/or (vi) a buffering agent. In addition, the present invention relates to the use of the liquid botulinum toxin formulation for therapeutic and cosmetic treatments.
La présente invention concerne une formulation de toxine botulique liquide comprenant : (i) une toxine botulinique, (ii) une protéine de stabilisation telle que l'albumine sérique humaine, (iii) un agent chélatant (par exemple, EDTA) ou un phosphate, et éventuellement (iv) un sel de calcium, de magnésium ou de zinc, (v) un agent de tonicité et/ou (vi) un agent tampon. De plus, la présente invention concerne l'utilisation de la formulation de toxine botulique liquide pour des traitements thérapeutiques et cosmétiques. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023156385A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023156385A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023156385A13</originalsourceid><addsrcrecordid>eNrjZDDy8QwM9XRRcPIPCfXx9Av1VQjxj_D0U3DzD_IN9XEM8fT3U3D0c1EIDXZVCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsaGpmbGFqaOhsbEqQIANngoBQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF</title><source>esp@cenet</source><creator>TAYLOR, Harold V ; KÜHBACH, Katja ; JATZKE, Claudia ; FINK, Klaus ; EISELE, Karl-Heinz</creator><creatorcontrib>TAYLOR, Harold V ; KÜHBACH, Katja ; JATZKE, Claudia ; FINK, Klaus ; EISELE, Karl-Heinz</creatorcontrib><description>The present invention relates to a liquid botulinum toxin formulation comprising: (i) botulinum toxin, (ii) a stabilizing protein such as human serum albumin, (iii) a chelating agent (e.g., EDTA) or phosphate, and optionally (iv) a salt of calcium, magnesium or zinc, (v) a tonicity agent and/or (vi) a buffering agent. In addition, the present invention relates to the use of the liquid botulinum toxin formulation for therapeutic and cosmetic treatments.
La présente invention concerne une formulation de toxine botulique liquide comprenant : (i) une toxine botulinique, (ii) une protéine de stabilisation telle que l'albumine sérique humaine, (iii) un agent chélatant (par exemple, EDTA) ou un phosphate, et éventuellement (iv) un sel de calcium, de magnésium ou de zinc, (v) un agent de tonicité et/ou (vi) un agent tampon. De plus, la présente invention concerne l'utilisation de la formulation de toxine botulique liquide pour des traitements thérapeutiques et cosmétiques.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=WO&NR=2023156385A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230824&DB=EPODOC&CC=WO&NR=2023156385A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAYLOR, Harold V</creatorcontrib><creatorcontrib>KÜHBACH, Katja</creatorcontrib><creatorcontrib>JATZKE, Claudia</creatorcontrib><creatorcontrib>FINK, Klaus</creatorcontrib><creatorcontrib>EISELE, Karl-Heinz</creatorcontrib><title>LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF</title><description>The present invention relates to a liquid botulinum toxin formulation comprising: (i) botulinum toxin, (ii) a stabilizing protein such as human serum albumin, (iii) a chelating agent (e.g., EDTA) or phosphate, and optionally (iv) a salt of calcium, magnesium or zinc, (v) a tonicity agent and/or (vi) a buffering agent. In addition, the present invention relates to the use of the liquid botulinum toxin formulation for therapeutic and cosmetic treatments.
La présente invention concerne une formulation de toxine botulique liquide comprenant : (i) une toxine botulinique, (ii) une protéine de stabilisation telle que l'albumine sérique humaine, (iii) un agent chélatant (par exemple, EDTA) ou un phosphate, et éventuellement (iv) un sel de calcium, de magnésium ou de zinc, (v) un agent de tonicité et/ou (vi) un agent tampon. De plus, la présente invention concerne l'utilisation de la formulation de toxine botulique liquide pour des traitements thérapeutiques et cosmétiques.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDy8QwM9XRRcPIPCfXx9Av1VQjxj_D0U3DzD_IN9XEM8fT3U3D0c1EIDXZVCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsaGpmbGFqaOhsbEqQIANngoBQ</recordid><startdate>20230824</startdate><enddate>20230824</enddate><creator>TAYLOR, Harold V</creator><creator>KÜHBACH, Katja</creator><creator>JATZKE, Claudia</creator><creator>FINK, Klaus</creator><creator>EISELE, Karl-Heinz</creator><scope>EVB</scope></search><sort><creationdate>20230824</creationdate><title>LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF</title><author>TAYLOR, Harold V ; KÜHBACH, Katja ; JATZKE, Claudia ; FINK, Klaus ; EISELE, Karl-Heinz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023156385A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>TAYLOR, Harold V</creatorcontrib><creatorcontrib>KÜHBACH, Katja</creatorcontrib><creatorcontrib>JATZKE, Claudia</creatorcontrib><creatorcontrib>FINK, Klaus</creatorcontrib><creatorcontrib>EISELE, Karl-Heinz</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAYLOR, Harold V</au><au>KÜHBACH, Katja</au><au>JATZKE, Claudia</au><au>FINK, Klaus</au><au>EISELE, Karl-Heinz</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF</title><date>2023-08-24</date><risdate>2023</risdate><abstract>The present invention relates to a liquid botulinum toxin formulation comprising: (i) botulinum toxin, (ii) a stabilizing protein such as human serum albumin, (iii) a chelating agent (e.g., EDTA) or phosphate, and optionally (iv) a salt of calcium, magnesium or zinc, (v) a tonicity agent and/or (vi) a buffering agent. In addition, the present invention relates to the use of the liquid botulinum toxin formulation for therapeutic and cosmetic treatments.
La présente invention concerne une formulation de toxine botulique liquide comprenant : (i) une toxine botulinique, (ii) une protéine de stabilisation telle que l'albumine sérique humaine, (iii) un agent chélatant (par exemple, EDTA) ou un phosphate, et éventuellement (iv) un sel de calcium, de magnésium ou de zinc, (v) un agent de tonicité et/ou (vi) un agent tampon. De plus, la présente invention concerne l'utilisation de la formulation de toxine botulique liquide pour des traitements thérapeutiques et cosmétiques.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023156385A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T10%3A15%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAYLOR,%20Harold%20V&rft.date=2023-08-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023156385A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |